Cannabis Law Report

AUGUST 24, 2022

Results from the third Cannabis as Medicine study. New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. 25 August 2022.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Medicinal Genomics

AUGUST 17, 2021

Medicinal Genomics Corp. Unlike other techniques, this multiplexing strategy verifies the performance of the assay when detecting pathogens, which minimizes false-negative results due to reaction set-up errors or failing experimental conditions. . About Medicinal Genomics Corporation.

Edibles 98

Edibles Medicine Agriculture Safety 98

Veriheal

APRIL 11, 2024

Medical cannabis is more popular than ever before, with 38 states having legalized some form of it for various health conditions. Now, more than 90% of citizens believe that the substance should be legal for medicinal and recreational use, something that would have seemed astonishing even a mere decade ago.

Patients 108

Patients Chronic Pain Marijuana Conditions 108

Cannabis Law Report

MARCH 19, 2022

publishers announces the launch of Psychedelic Medicine , an influential and dynamic peer-reviewed journal supporting the growing influential research and clinical applications in this pivotal field. For further information or submission inquiries about Psychedelic Medicine , please contact us. Mary Ann Liebert Inc.,

Medicine 52

Medicine Decriminalization Pharmaceutical Topical 52

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

MAY 10, 2022

More than half of all prescriptions for medicinal cannabis in Australia are written by doctors in Queensland, with prescriptions often given for conditions there is little evidence medicinal cannabis can treat, new research reveals. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

MMJ Recs

MAY 29, 2024

The perception and legalization of marijuana for medicinal use have undergone a significant shift across the United States. This program allows individuals with qualifying medical conditions to access marijuana for therapeutic purposes upon obtaining a medical marijuana card. Image by Iñaki del Olmo on Unsplash.

Marijuana 52

Marijuana Programs Patients Conditions 52

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

MMJ Recs

JANUARY 15, 2024

Today we’re here to tell you all you need to know about accessing and using medical marijuana in New Jersey! Governed by strict regulations, the program aims to provide patients with safe access to medicinal cannabis while maintaining a structured framework.

Chronic Pain 52

Chronic Pain Marijuana Programs Conditions 52

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.

Clinical Trials 249

Clinical Trials Chronic Pain Cannabinoids Patients 249

Cannabis Law Report

JULY 8, 2021

Many Australian consumers of medicinal cannabis access products that contain delta-9-tetrahydrocannabinol, better known as THC, which is a controlled drug under the Australian Poisons Standard, which provides a uniform approach to control the availability and accessibility of substances that can be used as ingredients in medicine. ‘A

Medicine 98

Medicine Research and Development Safety THC 98

MMJ Recs

MARCH 8, 2024

By shedding light on these financial aspects, individuals can gain a clearer understanding of the financial commitment required to access medicinal cannabis within Missouri’s healthcare framework. Established to offer relief to individuals suffering from debilitating conditions, the program has evolved through careful regulation.

Access 52

Access Programs Patients Dispensary 52

MMJ Recs

JANUARY 24, 2024

The landscape of healthcare and medicinal practices has undergone a transformative shift with the advent of medical marijuana programs across the United States. Today we’ll take a closer look at the Michigan Medical Marijuana Program, giving Michigan citizens all the info they need about accessing MMJ in the state.

Programs 52

Programs Marijuana Access Chronic Pain 52

Cannabis Law Report

DECEMBER 9, 2021

A 4-year-old Texas Original Compassionate Cultivation patient improves seizure control, behaviors and sleep with the company’s medicine. At the time of his diagnosis, he was one of only 400 people in the world with the condition. We remain committed to advancing safe, legal access to this powerful medicine. Emma Chase.

Conditions 52

Conditions Patients Sleep Medicine 52

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Under the regulations, no intermediaries are allowed to sell medicinal cannabis to patients.

Medicine 75

Medicine Research and Development Patients Programs 75

MMJ Recs

OCTOBER 18, 2023

With a growing number of New Jersey MMJ dispensaries offering a wide range of cannabis products, it’s essential for MMJ patients to stay informed about the options available. Patients can now access a wide variety of cannabis products to address their medical needs.

Dispensary 98

Dispensary Patients Education Strains 98

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Cannabis Law Report

JUNE 28, 2021

Our expertise in neurology and Curaleaf International’s knowledge of the pharmaceutical active processes of cannabinoids provide ideal conditions to bring innovative treatment to patients,” says Marco Castino, Head of Region Europe in Zambon. For more information about Curaleaf International, please visit [link].

Access 105

Access Research and Development Pharmaceutical Therapy 105

MMJ Recs

FEBRUARY 10, 2024

The journey begins with early debates around the medicinal use of cannabis, leading to the eventual establishment of the state’s medical marijuana program. Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views.

Research and Development 105

Research and Development Marijuana History Legislation 105

MMJ Recs

NOVEMBER 6, 2023

Best MMJ Strains in New York The availability of MMJ strains in New York has expanded over the years, offering patients a wider selection of options to address various medical conditions. With this card, you can visit state-licensed dispensaries to access the MMJ strains and products that align with your healthcare provider’s guidance.

Strains 105

Strains Chronic Pain Patients Dispensary 105

MMJ Recs

MARCH 6, 2024

Discover how legalization and regulation have influenced access and usage, and learn about the latest research and medical applications. Throughout this exploration, you’ll find practical information to help you understand the changing landscape of medical marijuana and its potential benefits for you and your community.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. However, by following a strategic guide, you can stay ahead of the curve and make informed choices regarding cannabis use. Differentiate between fact and fiction by accessing trustworthy information.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

MMJ Recs

MAY 25, 2024

However, in recent years, there has been a shift in attitudes towards cannabis, driven by increasing recognition of its medicinal properties and mounting evidence supporting its therapeutic benefits. Chronic pain conditions such as arthritis and neuropathy often find relief through ECS modulation, reducing inflammation and pain perception.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Veriheal

NOVEMBER 22, 2022

To have legal access to medical cannabis, residents of the state with a medical cannabis program must follow the rules set forth by the state for legal access to medical cannabis. Medical Cannabis Programs: Qualifying Conditions and Reciprocity. Not all states require qualifying conditions.

Programs 98

Programs Conditions Access Patients 98

Cannabis Law Report

DECEMBER 1, 2021

Ethics, Safety, and Abuse in Psychedelic Medicine. As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. Wednesday, December 8th from 12:00-2:00pm PST.

Safety 52

Safety Medicine Therapy Research and Development 52

Cannabis Law Report

AUGUST 19, 2019

There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.

Medicine 45

Medicine Patients Clinical Trials Access 45

Cannabis Cheri

SEPTEMBER 14, 2022

You didn't give me quite enough information. That said, I definitely think using cannabis edibles for pain management is something most people should try as cannabis does not have the serious side effects that come with prescription or even over-the-counter pain medicines. Access Now. What kind of pain? How severe? Easy to use!

Edibles 246

Edibles Sleep Topical Patients 246

MMJ Recs

OCTOBER 13, 2023

For patients seeking access to this valuable form of treatment, it’s essential to understand the complex web of regulations, legal requirements, and rights surrounding medical marijuana in the Golden State. These conditions encompass a range of ailments, including cancer, HIV/AIDS, glaucoma, and chronic pain.

Patients 52

Patients Law Cultivation Dispensary 52

Cannabis Law Report

FEBRUARY 27, 2020

Little Green Pharma signs three-year purchase agreement with Berlin-based DEMECAN for the sale and export of up to 1,000kg of dried flower or 48,000 units of medicinal cannabis oil product, or any combination thereof, per annum. The Agreement secures pricing that is a premium to LGP’s medicinal cannabis oil products sold in Australia.

Medicine 59

Medicine Oil Cultivation Pharmaceutical 59

MMJ Recs

OCTOBER 5, 2023

Whether you’re a potential patient or simply curious about MMJ, we’re here to provide you with all the essential information! Patients and industry stakeholders should stay informed about evolving regulations to ensure compliance with state laws and to promote the safe and responsible use of medical cannabis.

Dispensary 52

Dispensary Patients Treatment Conditions 52

MMJ Recs

DECEMBER 20, 2023

Virginia, once known for its conservative stance on cannabis, has made significant strides in embracing the medicinal properties of this plant. The establishment of medical marijuana dispensaries in Virginia represents a progressive approach to healthcare, offering patients alternative treatment options for various medical conditions.

Dispensary 52

Dispensary Marijuana Strains Patients 52

MMJ Recs

MARCH 28, 2024

This will empower you to make informed decisions about your healthcare journey Qualities to Look for in an MMJ Doctor in Iowa When searching for an MMJ doctor in Iowa, several key qualities are essential. Firstly, ensure the doctor is licensed to practice medicine in Iowa and registered with the state’s Medical Cannabidiol Board.

Patients 52

Patients Treatment Research and Development Therapy 52

FloridaMarijuana.net

JULY 16, 2018

On Nov 8th, 2016 the state of Florida legalized the use of medical marijuana, though it didn’t go into effect until March of 2017; the endorsement to the use of medical cannabis opened the doors to an alternative treatment for many different conditions. Proof of Florida residence. Patient intake form. Medical records & History.

Marijuana 189

Marijuana Patients Conditions Treatment 189

PrestoDoctor

SEPTEMBER 22, 2023

The Compassionate Use Act, enacted in 2015, allows for the medical use of low-THC cannabis oil by patients with certain qualifying conditions. These conditions include epilepsy, multiple sclerosis, terminal cancer, incurable neurological disorders, and a list of others. or less) and high levels of CBD.

Legalization 52

Legalization Dispensary Recreational Legislation 52

The Joint Blog

JUNE 4, 2021

Believe it or not, you actually need a license to do meaningful research on marijuana due to the fact that the United States Drug Enforcement Agency (DEA) has limited its access. So many of the breakthrough results from researches can only be found by those licensed medically to get obtain access. Cachexia or wasting syndrome.

Conditions 32

Conditions Chronic Pain Marijuana Research and Development 32

Cannabis Law Report

DECEMBER 5, 2021

The Multidisciplinary Association for Psychedelic Studies (MAPS) and Vine Ventures have announced the creation of a novel, social impact Special Purpose Vehicle (SPV), called the Regenerative Financing Vine (RFV), that will infuse $70 million into patient access infrastructure and research for MDMA-assisted therapy for PTSD.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98